Cardiovascular disease (CVD) is a major cause of morbidity and mortality in women worldwide, particularly those with adverse pregnancy outcomes such as gestational diabetes (GD). Although GD is an established marker of future cardiometabolic risk, the extent to which this risk can be influenced by sustained lifestyle changes remains unclear.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Omaveloxolone for Friedreich's Ataxia
Efficacy and Safety Studied Over 6 Years
- Psoriasis: therapy with biologics and TYK-2-i
Progress assessments based on current long-term and real-world data
- Hypertension: the most important facts for daily practice
Early dual antihypertensive therapy is usually indicated
- Escitalopram for anxiety disorders
Positive effect, but no immediate improvement in symptoms
- Helicobacter pylori infection
Simplified dual therapy beats quadruple regimen
- Gastric carcinoma
Ways of precision oncology
- Endometrial Cancer
Immunological drivers and new therapeutic pathways
- Exercise for type 1 diabetes